Literature DB >> 10874567

Steroid hormone receptors: an update.

M Beato1, J Klug.   

Abstract

Steroid hormones (SHs) are lipophilic molecules derived from cholesterol and synthesized in the adrenal cortex (glucocorticoids, mineralocorticoids, and adrenal androgens), the testes (testicular androgens, oestrogen), and the ovary and placenta (oestrogens and progestagens or progestins). SHs reach their target cells via the blood, where they are bound to carrier proteins, and because of their lipophilic nature pass the cell membrane by simple diffusion. Within the target cells SHs bind to steroid hormone receptors (SHRs), the key mediators of SH action, which are complexed to chaperones, e.g. heat shock protein 90 (Hsp90), that help other proteins to fold and prevent aggregation. SHRs are intracellular transcription factors that can be activated, among other possibilities, by the specific and high affinity binding of ligand to exert positive or negative effects on the expression of target genes. Binding of agonistic or antagonistic ligands leads to different allosteric changes of SHRs making them competent to exert positive or negative effects on the expression of target genes by different mechanisms. (i) After dissociation of chaperones the liganded SHR-complexes can bind to chromatin organized DNA sequences in the vicinity of target genes, termed hormone response elements (HREs). The HRE-recruited hormone-receptor-complexes are then able to initiate chromatin remodelling and to relay activating or repressing signals to the target genes transcription machinery; (ii) through protein-protein interactions with other sequence-specific transcription factors, SHRs can also regulate the activity of many genes that are switched on, for instance, during stress or an inflammatory response; (iii) the SH response can also be integrated in the intracellular signalling network via cross-talk of SHRs with signal transduction pathways that transmit extracellular signals via membrane receptors and activation of protein kinase cascades to nuclear transcription factors that activate various target genes. By all these different mechanisms SHRs modulate numerous and specific responses in a large variety of cells, whereby their particular effect depends on the physiological, cellular and genetic context.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874567     DOI: 10.1093/humupd/6.3.225

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  125 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 2.  How sex hormones promote skeletal muscle regeneration.

Authors:  Martina Velders; Patrick Diel
Journal:  Sports Med       Date:  2013-11       Impact factor: 11.136

Review 3.  Multifaceted origins of sex differences in the brain.

Authors:  Margaret M McCarthy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

4.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

5.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 6.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 7.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

Review 8.  Isoflavones and skeletal health: are these molecules ready for clinical application?

Authors:  S Migliaccio; J J B Anderson
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

9.  [Testosterone reduces the expression of keratinization-promoting genes in murine Meibomian glands].

Authors:  F Schirra; Z Gatzioufas; J Scheidt; B Seitz
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

10.  Chromatin context dominates estrogen regulation of pS2 gene expression.

Authors:  Akua K Oduro; Michael K Fritsch; Fern E Murdoch
Journal:  Exp Cell Res       Date:  2008-07-15       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.